基因型-话题@MedSci

#基因型#

105篇内容 | 2900人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890814, encodeId=a276189081475, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=重磅！吉利德泛基因型丙肝鸡尾酒疗法Epclusa获英国NICE批准, objectType=article, longId=78708, objectId=6ce7e8708b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ce7e8708b3, replyNumber=0, likeNumber=53, createdTime=2017-06-06, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ce7e8708b3, moduleTitle=重磅！吉利德泛基因型丙肝鸡尾酒疗法Epclusa获英国NICE批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ce7e8708b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890812, encodeId=1f7218908124f, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=丙肝重大进步！FDA批准吉利德全球泛基因型丙肝鸡尾酒Epclusa，治疗全部6种基因型丙肝, objectType=article, longId=71851, objectId=6d8ce185139, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d8ce185139, replyNumber=0, likeNumber=75, createdTime=2016-08-28, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d8ce185139, moduleTitle=丙肝重大进步！FDA批准吉利德全球泛基因型丙肝鸡尾酒Epclusa，治疗全部6种基因型丙肝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d8ce185139)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890811, encodeId=aa2d1890811e4, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=重磅！吉利德全球泛基因型丙肝鸡尾酒疗法Epclusa（sof/vel）获欧盟CHMP支持批准, objectType=article, longId=69401, objectId=ecb0694019b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecb0694019b, replyNumber=0, likeNumber=66, createdTime=2016-07-23, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecb0694019b, moduleTitle=重磅！吉利德全球泛基因型丙肝鸡尾酒疗法Epclusa（sof/vel）获欧盟CHMP支持批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecb0694019b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890805, encodeId=a377189080552, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=FDA批准Zepatier用于治疗基因型1型和4型的慢性病毒性丙肝, objectType=article, longId=62787, objectId=f72062e8788, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f72062e8788, replyNumber=0, likeNumber=66, createdTime=2016-08-25, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f72062e8788, moduleTitle=FDA批准Zepatier用于治疗基因型1型和4型的慢性病毒性丙肝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f72062e8788)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890809, encodeId=55c0189080900, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=丙肝鸡尾酒Zepatier头对头III期治疗基因型1/4丙肝疗效及安全性显著优于sofosbuvir+pegIFN/RBV方案, objectType=article, longId=66962, objectId=bde56696205, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bde56696205, replyNumber=0, likeNumber=70, createdTime=2016-05-13, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bde56696205, moduleTitle=丙肝鸡尾酒Zepatier头对头III期治疗基因型1/4丙肝疗效及安全性显著优于sofosbuvir+pegIFN/RBV方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bde56696205)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890806, encodeId=f2f01890806e9, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=Hepatology：DCV-SOF-RBV治疗HCV基因型3感染的晚期肝脏疾病患者（ALLY-3+）, objectType=article, longId=64417, objectId=ed9d6441e3a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed9d6441e3a, replyNumber=0, likeNumber=71, createdTime=2017-01-11, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed9d6441e3a, moduleTitle=Hepatology：DCV-SOF-RBV治疗HCV基因型3感染的晚期肝脏疾病患者（ALLY-3+）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed9d6441e3a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890802, encodeId=849918908021d, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=Neurology：神经科Aicardi-Goutières综合征患者的CT和MRI表现与基因型有关, objectType=article, longId=59259, objectId=72265925927, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72265925927, replyNumber=0, likeNumber=45, createdTime=2016-05-11, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72265925927, moduleTitle=Neurology：神经科Aicardi-Goutières综合征患者的CT和MRI表现与基因型有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72265925927)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890807, encodeId=53e8189080e55, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=2016 肿瘤异质性学术研讨会——从基因型到表观调控, objectType=article, longId=64833, objectId=91b8648330f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91b8648330f, replyNumber=0, likeNumber=32, createdTime=2016-08-21, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91b8648330f, moduleTitle=2016 肿瘤异质性学术研讨会——从基因型到表观调控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91b8648330f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890813, encodeId=e4d418908136a, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=丙肝重大里程碑！吉利德全球泛基因型丙肝鸡尾酒Epclusa获美国和欧盟批准！, objectType=article, longId=72482, objectId=cf02e24823e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf02e24823e, replyNumber=0, likeNumber=46, createdTime=2017-04-18, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf02e24823e, moduleTitle=丙肝重大里程碑！吉利德全球泛基因型丙肝鸡尾酒Epclusa获美国和欧盟批准！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf02e24823e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890808, encodeId=d033189080810, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=2016国际肝病会议：治疗基因型1型和4型HCV感染，Elbasvir/grazoprevir方案的安全性和疗效性更优, objectType=article, longId=66791, objectId=ff0366e9153, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff0366e9153, replyNumber=0, likeNumber=66, createdTime=2016-12-18, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff0366e9153, moduleTitle=2016国际肝病会议：治疗基因型1型和4型HCV感染，Elbasvir/grazoprevir方案的安全性和疗效性更优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff0366e9153)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890810, encodeId=fe3c18908101e, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=默沙东丙肝鸡尾酒Zepatier获欧盟CHMP支持批准，用于基因型1/4丙肝, objectType=article, longId=69399, objectId=49dd69399c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49dd69399c2, replyNumber=0, likeNumber=99, createdTime=2017-05-09, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49dd69399c2, moduleTitle=默沙东丙肝鸡尾酒Zepatier获欧盟CHMP支持批准，用于基因型1/4丙肝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49dd69399c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890801, encodeId=43e71890801b5, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=NEJM：HCV基因型2或3患者——sofosbuvir/velpatasvir优于标准治疗方案, objectType=article, longId=59145, objectId=256459145ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=256459145ee, replyNumber=0, likeNumber=72, createdTime=2016-04-07, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=256459145ee, moduleTitle=NEJM：HCV基因型2或3患者——sofosbuvir/velpatasvir优于标准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=256459145ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890803, encodeId=78cf189080343, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=NEJM：Sofosbuvir 及Velpatasvir治疗基因型1、2、4、5及 6的HCV感染患者的效果, objectType=article, longId=61524, objectId=6a3c6152469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a3c6152469, replyNumber=0, likeNumber=69, createdTime=2016-09-15, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a3c6152469, moduleTitle=NEJM：Sofosbuvir 及Velpatasvir治疗基因型1、2、4、5及 6的HCV感染患者的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a3c6152469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890804, encodeId=d7b5189080451, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=吉利德泛基因型丙肝鸡尾酒疗法SOF/VEL获FDA优先审查资格，将极大简化丙肝临床治疗, objectType=article, longId=61804, objectId=93ed618041a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93ed618041a, replyNumber=0, likeNumber=55, createdTime=2016-06-24, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93ed618041a, moduleTitle=吉利德泛基因型丙肝鸡尾酒疗法SOF/VEL获FDA优先审查资格，将极大简化丙肝临床治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93ed618041a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890800, encodeId=17331890800f1, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=Anesth Analg：ADRB2基因型可影响剖宫产术对去氧肾上腺素的需求量, objectType=article, longId=53114, objectId=269d5311471, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=269d5311471, replyNumber=0, likeNumber=71, createdTime=2015-07-11, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=269d5311471, moduleTitle=Anesth Analg：ADRB2基因型可影响剖宫产术对去氧肾上腺素的需求量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=269d5311471)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890799, encodeId=01ff1890e999f, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=Nat Neurosci：自闭症基因型与表型的关系, objectType=article, longId=44998, objectId=143144998b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=143144998b2, replyNumber=0, likeNumber=93, createdTime=2015-08-15, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=143144998b2, moduleTitle=Nat Neurosci：自闭症基因型与表型的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=143144998b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890798, encodeId=e8ed1890e9859, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=NEJM：基因型指导华法林给药剂量未能显著改善抗凝疗效（COAG研究）, objectType=article, longId=29344, objectId=d4e729344f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4e729344f0, replyNumber=0, likeNumber=72, createdTime=2014-07-30, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4e729344f0, moduleTitle=NEJM：基因型指导华法林给药剂量未能显著改善抗凝疗效（COAG研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4e729344f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890794, encodeId=a9851890e94ec, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=FDA批准雅培HCV基因型检测试剂盒上市, objectType=article, longId=21380, objectId=378b21380f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=378b21380f4, replyNumber=0, likeNumber=64, createdTime=2014-04-23, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=378b21380f4, moduleTitle=FDA批准雅培HCV基因型检测试剂盒上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=378b21380f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890797, encodeId=837c1890e9794, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=NEJM：EU-PACT研究发现按基因型确定华法林剂量优于使用临床标准剂量, objectType=article, longId=27443, objectId=db262e44387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db262e44387, replyNumber=0, likeNumber=58, createdTime=2014-05-11, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db262e44387, moduleTitle=NEJM：EU-PACT研究发现按基因型确定华法林剂量优于使用临床标准剂量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db262e44387)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890796, encodeId=8d781890e9650, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, objectTitle=J HEPATOL：HBsAg水平和白介素-28B基因型可预测尿毒症患者HCV的自发清除率, objectType=article, longId=25249, objectId=9776252499c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9776252499c, replyNumber=0, likeNumber=74, createdTime=2014-06-04, rootId=0, userName=kzlchina, userId=f984116, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9776252499c, moduleTitle=J HEPATOL：HBsAg水平和白介素-28B基因型可预测尿毒症患者HCV的自发清除率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9776252499c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

基因型

2020-05-29

kzlchina (审核中...)

前往app查看评论内容

#基因型#

重磅！吉利德泛基因型丙肝鸡尾酒疗法Epclusa获英国NICE批准

2017-06-06

仁心济世 (审核中...)

前往app查看评论内容

#基因型#

丙肝重大进步！FDA批准吉利德全球泛基因型丙肝鸡尾酒Epclusa，治疗全部6种基因型丙肝

2016-08-28

kzlchina (审核中...)

前往app查看评论内容

#基因型#

重磅！吉利德全球泛基因型丙肝鸡尾酒疗法Epclusa（sof/vel）获欧盟CHMP支持批准

2016-07-23

kzlchina (审核中...)

前往app查看评论内容

#基因型#

FDA批准Zepatier用于治疗基因型1型和4型的慢性病毒性丙肝

2016-08-25

kzlchina (审核中...)

前往app查看评论内容

#基因型#

丙肝鸡尾酒Zepatier头对头III期治疗基因型1/4丙肝疗效及安全性显著优于sofosbuvir+pegIFN/RBV方案

2016-05-13

kzlchina (审核中...)

前往app查看评论内容

#基因型#

Hepatology：DCV-SOF-RBV治疗HCV基因型3感染的晚期肝脏疾病患者（ALLY-3+）

2017-01-11

kzlchina (审核中...)

前往app查看评论内容

#基因型#

Neurology：神经科Aicardi-Goutières综合征患者的CT和MRI表现与基因型有关

2016-05-11

kzlchina (审核中...)

前往app查看评论内容

#基因型#

2016 肿瘤异质性学术研讨会——从基因型到表观调控

2016-08-21

kzlchina (审核中...)

前往app查看评论内容

#基因型#

丙肝重大里程碑！吉利德全球泛基因型丙肝鸡尾酒Epclusa获美国和欧盟批准！

2017-04-18

kzlchina (审核中...)

前往app查看评论内容

#基因型#

2016国际肝病会议：治疗基因型1型和4型HCV感染，Elbasvir/grazoprevir方案的安全性和疗效性更优

2016-12-18

kzlchina (审核中...)

前往app查看评论内容

#基因型#

默沙东丙肝鸡尾酒Zepatier获欧盟CHMP支持批准，用于基因型1/4丙肝

2017-05-09

kzlchina (审核中...)

前往app查看评论内容

#基因型#

NEJM：HCV基因型2或3患者——sofosbuvir/velpatasvir优于标准治疗方案

2016-04-07

kzlchina (审核中...)

前往app查看评论内容

#基因型#

NEJM：Sofosbuvir 及Velpatasvir治疗基因型1、2、4、5及 6的HCV感染患者的效果

2016-09-15

kzlchina (审核中...)

前往app查看评论内容

#基因型#

吉利德泛基因型丙肝鸡尾酒疗法SOF/VEL获FDA优先审查资格，将极大简化丙肝临床治疗

2016-06-24

kzlchina (审核中...)

前往app查看评论内容

#基因型#

Anesth Analg：ADRB2基因型可影响剖宫产术对去氧肾上腺素的需求量

2015-07-11

kzlchina (审核中...)

前往app查看评论内容

#基因型#

Nat Neurosci：自闭症基因型与表型的关系

2015-08-15

kzlchina (审核中...)

前往app查看评论内容

#基因型#

NEJM：基因型指导华法林给药剂量未能显著改善抗凝疗效（COAG研究）

2014-07-30

kzlchina (审核中...)

前往app查看评论内容

#基因型#

FDA批准雅培HCV基因型检测试剂盒上市

2014-04-23

kzlchina (审核中...)

前往app查看评论内容

#基因型#

NEJM：EU-PACT研究发现按基因型确定华法林剂量优于使用临床标准剂量

2014-05-11

kzlchina (审核中...)

前往app查看评论内容

#基因型#

J HEPATOL：HBsAg水平和白介素-28B基因型可预测尿毒症患者HCV的自发清除率

2014-06-04

科室
- - 订阅+
  - 更多科室
工具
服务